What is Gilead Sciences's net change in cash?

Gilead Sciences (GILD) reported net change in cash of $65M in Q1 2026.

How has Gilead Sciences's net change in cash changed year-over-year?

Gilead Sciences's net change in cash increased by 103.1% year-over-year, from -$2.07B to $65M.

What is the long-term trend for Gilead Sciences's net change in cash?

Over 2 years (2022 to 2024), Gilead Sciences's net change in cash has grown at a 626.5% compound annual growth rate (CAGR), from $74M to $3.91B.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Gilead Sciences GILD Net Change in Cash

Net Change in Cash at other companies

Bristol-Myers SquibbBMY

-$635M-220%

IncyteINCY

$363.28M+43.1%

ImmunityBio, Inc.IBRX

$117.04M+241%

PrecigenPGEN

-$22.75M+3.0%

AnaptysBio, Inc.ANAB

$10.27M+142%

Iovance Biotherapeutics, Inc.IOVA

$33.44M-40.3%

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$158.77B+19.1%

Enterprise value$173.32B+13.2%

P/E17.2×-3.9×

P/S5.3×+0.7×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's net change in cash?: Gilead Sciences (GILD) reported net change in cash of $65M in Q1 2026.
How has Gilead Sciences's net change in cash changed year-over-year?: Gilead Sciences's net change in cash increased by 103.1% year-over-year, from -$2.07B to $65M.
What is the long-term trend for Gilead Sciences's net change in cash?: Over 2 years (2022 to 2024), Gilead Sciences's net change in cash has grown at a 626.5% compound annual growth rate (CAGR), from $74M to $3.91B.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.